288 related articles for article (PubMed ID: 30015562)
1. T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response.
Moise L; M Biron B; Boyle CM; Kurt Yilmaz N; Jang H; Schiffer C; M Ross T; Martin WD; De Groot AS
Hum Vaccin Immunother; 2018; 14(9):2203-2207. PubMed ID: 30015562
[TBL] [Abstract][Full Text] [Related]
2. Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design.
De Groot AS; Moise L; Liu R; Gutierrez AH; Terry F; Koita OA; Ross TM; Martin W
Hum Vaccin Immunother; 2014; 10(2):256-62. PubMed ID: 24525618
[TBL] [Abstract][Full Text] [Related]
3. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
[TBL] [Abstract][Full Text] [Related]
4. Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach.
Sun Z; Wang Q; Li G; Li J; Chen S; Qin T; Ma H; Peng D; Liu X
Microbiol Spectr; 2021 Oct; 9(2):e0068721. PubMed ID: 34585985
[TBL] [Abstract][Full Text] [Related]
5. Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.
De Groot AS; Ardito M; Terry F; Levitz L; Ross T; Moise L; Martin W
Hum Vaccin Immunother; 2013 May; 9(5):950-6. PubMed ID: 23807079
[TBL] [Abstract][Full Text] [Related]
6. Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice.
Moise L; Meyers LM; Jang H; Grizotte-Lake M; Boyle CM; McGonnigal B; Ge P; Ross TM; De Groot AS
Hum Vaccin Immunother; 2022 Nov; 18(4):2082191. PubMed ID: 35704783
[TBL] [Abstract][Full Text] [Related]
7. H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus.
Rudenko L; Isakova-Sivak I; Donina S
Vaccine; 2013 Oct; 31(42):4702-5. PubMed ID: 23988294
[TBL] [Abstract][Full Text] [Related]
8. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
[TBL] [Abstract][Full Text] [Related]
9. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
Li X; Gao Y; Ye Z
J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
[TBL] [Abstract][Full Text] [Related]
11. Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens.
Hu J; Liang Y; Hu Z; Wang X; Gu M; Li R; Ma C; Liu X; Hu S; Chen S; Peng D; Jiao X; Liu X
Arch Virol; 2019 Mar; 164(3):807-817. PubMed ID: 30671655
[TBL] [Abstract][Full Text] [Related]
12. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
Zhang L; Jia N; Li J; Han Y; Cao W; Wang S; Huang Z; Lu S
Hum Vaccin Immunother; 2014; 10(7):1949-58. PubMed ID: 25424804
[TBL] [Abstract][Full Text] [Related]
13. Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge.
Wang X; Fu W; Yuan S; Yang X; Song Y; Liu L; Chi Y; Cheng T; Xing M; Zhang Y; Zhang C; Yang Y; Zhu C; Zhang X; Xiong S; Xu J; Zhou D
Sci Rep; 2017 May; 7(1):1854. PubMed ID: 28500340
[TBL] [Abstract][Full Text] [Related]
14. Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses.
Zheng D; Chen S; Qu D; Chen J; Wang F; Zhang R; Chen Z
Vaccine; 2016 Dec; 34(51):6464-6471. PubMed ID: 27866773
[TBL] [Abstract][Full Text] [Related]
15. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
16. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs.
Ridenour C; Johnson A; Winne E; Hossain J; Mateu-Petit G; Balish A; Santana W; Kim T; Davis C; Cox NJ; Barr JR; Donis RO; Villanueva J; Williams TL; Chen LM
Influenza Other Respir Viruses; 2015 Sep; 9(5):263-70. PubMed ID: 25962412
[TBL] [Abstract][Full Text] [Related]
17. Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9.
Tarrahimofrad H; Rahimnahal S; Zamani J; Jahangirian E; Aminzadeh S
Sci Rep; 2021 Dec; 11(1):24485. PubMed ID: 34966175
[TBL] [Abstract][Full Text] [Related]
18. Divergent H7 immunogens offer protection from H7N9 virus challenge.
Krammer F; Albrecht RA; Tan GS; Margine I; Hai R; Schmolke M; Runstadler J; Andrews SF; Wilson PC; Cox RJ; Treanor JJ; GarcĂa-Sastre A; Palese P
J Virol; 2014 Apr; 88(8):3976-85. PubMed ID: 24453375
[TBL] [Abstract][Full Text] [Related]
19. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
[TBL] [Abstract][Full Text] [Related]
20. Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge.
Jang H; Meyers LM; Boyle C; De Groot AS; Moise L; Ross TM
Hum Vaccin Immunother; 2020 Sep; 16(9):2042-2050. PubMed ID: 32783766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]